<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Using <z:e sem="disease" ids="C0042974" disease_type="Disease or Syndrome" abbrv="">von Willebrand</z:e> Factor (vWF) as a marker of endothelial function, previous studies have shown that the development of <z:mp ids='MP_0002959'>microalbuminuria</z:mp> is associated with the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> in individuals with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>We tested the hypothesis that <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> is already evident in normoalbuminuric individuals with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: We used laser Doppler imaging scanning to measure vasodilation in the forearm skin in response to iontophoresis of 1% <z:chebi fb="9" ids="15355">acetylcholine</z:chebi> (endothelium-dependent) and 1% <z:chebi fb="0" ids="29321">sodium nitroprusside</z:chebi> (endothelium-independent) </plain></SENT>
<SENT sid="3" pm="."><plain>Multiple indicators of endothelial function--soluble intercellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule (sICAM), soluble vascular cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule (sVCAM), vWF, and microvascular reactivity--were measured in 20 healthy control subjects, 45 normoalbuminuric (urinary albumin/<z:chebi fb="0" ids="16737">creatinine</z:chebi> ratio &lt; 30 micrograms/mg) individuals with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, and 14 microalbuminuric (urinary albumin/<z:chebi fb="0" ids="16737">creatinine</z:chebi> ratio between 30 and 300 micrograms/mg) individuals with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Serum sICAM and sVCAM levels were elevated in the normoalbuminuric (305 +/- 120, 851 +/- 284 ng/ml) and microalbuminuric (300 +/- 89, 845 +/- 252 ng/ml) individuals with <z:mp ids='MP_0002055'>diabetes</z:mp> when compared with the healthy control subjects (213 +/- 58, 661 +/- 176 ng/ml) (P &lt; 0.01) </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, the microvascular endothelium-dependent and -independent vasodilation was reduced in the normoalbuminuric (76 +/- 44, 70 +/- 33) (percent increase in perfusion over baseline) and microalbuminuric (74 +/- 41, 73 +/- 28) individuals with <z:mp ids='MP_0002055'>diabetes</z:mp> compared with healthy control subjects (126 +/- 67, 120 +/- 47) (P &lt; 0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>In contrast, plasma vWF was elevated only in the microalbuminuric individuals with <z:mp ids='MP_0002055'>diabetes</z:mp> (129 +/- 35%) compared with the normoalbuminuric individuals with <z:mp ids='MP_0002055'>diabetes</z:mp> (110 +/- 34) and healthy control subjects (111.3 +/- 39) (P &lt; 0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>On stepwise multivariate analysis, fasting blood <z:chebi fb="105" ids="17234">glucose</z:chebi> was the most important contributing factor to the variation in microvascular reactivity and sVCAM, whereas <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> (by homeostasis model assessment) was the most important contributing factor to the variation in sICAM </plain></SENT>
<SENT sid="8" pm="."><plain>Addition of <z:hpo ids='HP_0000001'>all</z:hpo> clinical and biochemical measures explained only 15-22% of the variation in sICAM, sVCAM, and microvascular reactivity </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Multiple markers of <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> were evident in normoalbuminuric individuals with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>The pathogenic process of vasculopathy in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> occurs early and may be operative before the development of <z:mp ids='MP_0002959'>microalbuminuria</z:mp> </plain></SENT>
</text></document>